Valeant Acquires Devicemaker to Broaden Skin Product Portfolio

Drug Industry Daily
A A
Looking to add to its growing skin care product portfolio, Valeant Pharmaceuticals said Monday it will acquire medical devicemaker Solta Medical for $250 million.

To View This Article:

Login

Subscribe To Drug Industry Daily